Natural Beauty Bio-Technology Limited

As of June 30, 2026, Natural Beauty Biotechnology Ltd. carries a market capitalization of 122.28M, placing it among publicly traded companies globally. Its enterprise value stands at 161.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Natural Beauty Biotechnology Ltd. has 2.00B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Natural Beauty Biotechnology Ltd. maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on August 21, 2026, Natural Beauty Biotechnology Ltd.'s stock has declined approximately 15.25% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.14.

As of June 30, 2026, Natural Beauty Biotechnology Ltd. holds 14.81M in cash and equivalents against 54.16M in total debt, resulting in a net debt position of 35.70M. Total book value stands at 54.01M, with working capital of -3.20M providing operational flexibility.